Average Co-Inventor Count = 6.04
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cardioxyl Pharmaceuticals, Inc. (37 from 37 patents)
2. Johns Hopkins University (18 from 3,687 patents)
3. Hoffmann-la Roche Inc. (6 from 4,945 patents)
4. Respivert Limited (6 from 63 patents)
5. Oxagen Limited (5 from 12 patents)
6. Pfizer Italia S.r.l. (4 from 23 patents)
7. Storm Therapeutics Limited (3 from 3 patents)
8. Chdi Foundation, Inc. (2 from 53 patents)
9. Roche Palo Alto LLC (1 from 322 patents)
10. Pharmacia Italia S.p.a. (26 patents)
11. Atopix Therapeutics Limited (9 patents)
12. Lisa Marie Frost (0 patent)
13. Stephen Martin Courtney (0 patent)
14. John P. Toscano (0 patent)
15. Vincent Jacob Kalish (0 patent)
64 patents:
1. 12358915 - METTL3 inhibitory compounds
2. 12195458 - Polyheterocyclic compounds as METTL3 inhibitors
3. 12186301 - Nitroxyl donors with improved therapeutic index
4. 11786501 - Nitroxyl donors with improved therapeutic index
5. 11725010 - Polyheterocyclic compounds as METTL3 inhibitors
6. 11306056 - N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
7. 11304924 - Pharmaceutical compositions comprising nitroxyl donors
8. 11273143 - Nitroxyl donors with improved therapeutic index
9. 10829445 - N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
10. 10792273 - Nitroxyl donors with improved therapeutic index
11. 10730828 - N-hydroxylsulfonamide derivatives as nitroxyl donors
12. 10723704 - Pyrazolone derivatives as nitroxyl donors
13. 10548872 - Pharmaceutical compositions comprising nitroxyl donors
14. 10517847 - Nitroxyl donors with improved therapeutic index
15. 10487049 - N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors